Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00124462 · ClinicalTrials.gov registry record · NA

Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis

A NA study, sponsored by Boston University.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT00124462 is a NA study that has completed, run by Boston University. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00124462, a NA study, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The overall objective of this 3-year project is to determine whether the provision of realignment therapy in patients with medial knee osteoarthritis (OA) relieves knee pain and improves function. The researchers will test the hypothesis that compared to control treatment, the use of realignment therapy (valgus knee brace + motion control shoes + orthosis) is effective in medial knee OA. The specific aims are: * To undertake a 30 week randomized crossover clinical trial in patients with medial knee osteoarthritis to determine whether provision of realignment therapy leads to lower pain scores and improved function during the time of this treatment than during the use of a placebo treatment; * To perform an open label follow-up study to track use and effectiveness of treatment. This project will be co-funded by DonJoy Orthopedic, a knee bracing company.

Interventions

  • DEVICE Realigning knee brace and custom orthodic
  • DEVICE Non realigning knee brace and flat orthodic

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2008-03
Est. Completion 2008-11
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT00124462

The ClinicalTrials.gov registry entry for NCT00124462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Realigning knee brace and custom orthodic is the first listed.

NCT00124462 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00124462 about?

NCT00124462 is a clinical study titled "Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis". The overall objective of this 3-year project is to determine whether the provision of realignment therapy in patients with medial knee osteoarthritis (OA) relieves knee pain and improves function. The researchers will test the hypothesis that compared to control treatment, the use of realignment the...

What is the current status of trial NCT00124462?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2008-03. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00124462?

The interventions under investigation include: Realigning knee brace and custom orthodic (DEVICE), Non realigning knee brace and flat orthodic (DEVICE).

Who is sponsoring clinical trial NCT00124462?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.